Skip to content
6-K

Foreign Interim / Material

Adagene Inc. ADAG

0001410578-24-001109

← back to feed
Filed
Jul 25, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Long Term Debt Q2 2024 · Jun 30, 2024 $4.56M
Long Term Debt Q2 2024 · Dec 31, 2023 $13.54M
Short Term Debt Q2 2024 · Jun 30, 2024 $15.97M
Short Term Debt Q2 2024 · Dec 31, 2023 $8.4M
Short Term Investments Q2 2024 · Jun 30, 2024 $0
Short Term Investments Q2 2024 · Dec 31, 2023 $0
Cash And Equivalents Q2 2024 · Jun 30, 2024 $95.67M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $109.93M
Current Liabilities Q2 2024 · Jun 30, 2024 $39.52M
Current Liabilities Q2 2024 · Dec 31, 2023 $31.46M
Total Liabilities Q2 2024 · Jun 30, 2024 $44.19M
Total Liabilities Q2 2024 · Dec 31, 2023 $45.17M
Current Assets Q2 2024 · Jun 30, 2024 $98.8M
Current Assets Q2 2024 · Dec 31, 2023 $113.44M
Total Assets Q2 2024 · Jun 30, 2024 $100.78M
Total Assets Q2 2024 · Dec 31, 2023 $115.73M
Shares Diluted Q2 2024 · Jun 30, 2023 54.6M sh
Capex Q2 2024 · Jun 30, 2023 $30.97K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$13.43M
Stockholders Equity Q2 2024 · Jun 30, 2023 $82.79M
Stockholders Equity Q2 2024 · Dec 31, 2022 $83.09M
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.08
Eps Basic Q2 2024 · Jun 30, 2023 −$0.08
Sga Expense Q2 2024 · Jun 30, 2023 $4.47M
Rd Expense Q2 2024 · Jun 30, 2023 $21.29M
Net Income Q2 2024 · Jun 30, 2023 −$4.11M
Operating Income Q2 2024 · Jun 30, 2023 −$5.05M
Revenue Q2 2024 · Jun 30, 2023 $17.3M